ZYBERNO
Stock Report
Updated Sep 1, 2026

TALPHERA, INC. (TLPH)

Healthcare • NASDAQ

$1.19

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
25.0/100
POOR BUSINESS
TALPHERA, INC. (TLPH) scores 25/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-87.3%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-1,498,700.0%)
Return on Capital (Capital Efficiency):CRITICAL (-115.5%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

TALPHERA, INC. (TLPH) stock report — Zyberno Score 25/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, TLPH generated -$12.68M in Owner Earnings. Reinvestment rate: 0.0%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.19
Market Cap:$89.88M

Valuation Multiples (3)

P/B Ratio:6.24x
P/S Ratio:89,877.01x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$72.80M

Price Action & Momentum (3)

Momentum Percentile:94 / 100
% of 52-Week High:75.8%
B. Profitability Assessment

Return Metrics (5)

ROA:-51.4%
Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%

Margin Analysis (3)

Operating Margin Ttm:-1,498,700.0%
Net Margin Ttm:-1,507,600.0%
Ebitda Margin:-1,498,700.0%

TTM Performance (2)

Operating Margin Ttm:-1,498,700.0%
Net Margin Ttm:-1,507,600.0%

Yield Metrics (2)

Earnings Yield:-$19.51
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:86.5%
Latest Earnings Filed:2023-11-14

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:4.29x
Quick Ratio:4.29x
Cash Ratio:4.08x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:13,799,000.00
Cash And Cash Equivalents:17,076,000.00
Long Term Debt:$0.00
Net Debt:-$17.08M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.00K
Linear Growth: -50.0%
📊 Click to view full TLPH Revenue analysis & methodology →
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$14.99M

Bottom Line Performance (3)

-$15.08M
Income Before Tax:$56.75M
Ebitda Ttm:-14,987,000.00

Operating Expenses (5)

Operating Expenses:14,748,000.00
R And D Expense:6,704,000.00
Sga Expense:8,044,000.00
Income Tax Expense:$5.00K
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:-1,498,700.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$26.81M
Current Assets:$17.99M
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$8.82M

Liability Structure (4)

Total Liabilities:12,400,000.00
Current Liabilities:4,188,000.00
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$14.41M
Retained Earnings:-$478.39M
Common Stock:200,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:3,151,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:243,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$11.29M-$12.68M

Investment Activities (2)

Investing Cash Flow:-$2.71M
Capital Expenditures Ttm:0.00

Financing Activities (3)

Financing Cash Flow:$4.04M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (2)

EPS (Basic TTM):-0.24
Earnings Per Share Ttm:-$0.20

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.00
Operating Cash Flow Per Share:-$0.15

Book Value & Capital (2)

Book Value Per Share:$0.19
Cash Per Share:0.23

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.00x
Working Capital Turnover Ttm:0.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:1,150,115.00
Cash Conversion Cycle:-1,152,113.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$12.68M

Damodaran Growth Analysis (2)

Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%

Other Growth Rates (1)

Book Value Growth Rate (Linear):-16.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:TLPH
Company Name:TALPHERA, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:75.53M
Shares Outstanding Basic:75.53M
Shares Outstanding Diluted:16.76M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 04:41:13 UTC
Data Timestamp:2026-08-20T13:55:37.218471
Scroll to Top